Listar por autor "Arizón-del-Prado, José M."

Mostrando ítems 21-24 de 24

    • Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2015) 

      González-Vílchez, Francisco; Segovia-Cubero, Javier; Almenar, Luis; Crespo-Leiro, María Generosa; Arizón-del-Prado, José M.; Sousa-Casasnovas, Iago; Delgado-Jiménez, Juan F.; Roig, Eulàlia; Sobrino, José Manuel; González-Costello, José (Elsevier para Sociedad Española de Cardiología, 2016-10-01)
      [Abstract] Introduction and objectives. The present article reports the characteristics and results of heart transplants in Spain since this therapeutic modality was first used in May 1984. Methods. We describe the main ...

    • Steroids withdrawal during the first year after heart transplantation and its association with changes in renal function in a two year follow-up. RESTCO study 

      Crespo-Leiro, María Generosa; Paniagua-Martín, María J.; Gómez-Bueno, Manuel; González-Vílchez, Francisco; Lambert Rodríguez, José Luis; Fernández-Yáñez, Juan; Brossa-Loidi, Vicens; Lage-Gallé, Ernesto; Arizón-del-Prado, José M.; Almenar-Bonet, Luis; Blasco-Peiró, Teresa; De la Fuente-Galán, Luis; Garrido-Bravo, Iris P.; Muñiz, Javier; Delgado-Jiménez, Juan F. (Elsevier, 2014)

    • The Falling Incidence of Hematologic Cancer After Heart Transplantation 

      Crespo-Leiro, María Generosa; Delgado-Jiménez, Juan F.; López, L.; Alonso-Pulpón, Luis; González-Vílchez, Francisco; Almenar-Bonet, Luis; Rábago, Gregorio; Pérez-Villa, Félix; Paniagua-Martín, María J.; Arizón-del-Prado, José M.; Sousa-Casasnovas, Iago; Manito-Lorite, Nicolás; Díaz Molina, Beatriz; Pascual Figal, Domingo A.; Lage-Gallé, Ernesto; Blasco-Peiró, Teresa; De la Fuente-Galán, Luis; Muñiz, Javier (Wiley, 2014-10-01)
      [Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the ...

    • The prognosis of noncutaneous, nonlymphomatous malignancy after heart transplantation: data from the spanish post-heart transplant tumour registry 

      Crespo-Leiro, María Generosa; Alonso-Pulpón, Luis; Villa-Arranz, Adolfo; Brossa-Loidi, Vicens; Almenar-Bonet, Luis; González-Vílchez, Francisco; Delgado-Jiménez, Juan F.; Manito-Lorite, Nicolás; Díaz Molina, Beatriz; Rábago, Gregorio; Arizón-del-Prado, José M.; Romero-Rodríguez, N.; Brossa, V.; Blasco-Peiró, Teresa; Pascual Figal, Domingo A.; De la Fuente-Galán, Luis; Muñiz, Javier (Elsevier, 2010-10-21)
      [Abstract] Introduction. Malignancy is a major complication in the management of solid organ transplant patients. Skin cancers show a better prognosis than other neoplasms, but not all others are equal: Ideally, patient ...